Current Status and Evolution of Immunotherapy in Glioma Management
Jiaying Liu(Air Force Medical University), Jintao Gu(Air Force Medical University), Maorong Zhu(Air Force Medical University), Guangzhao Yang(Xijing Hospital), Zhengcong Cao(Air Force Medical University), Cheng Zou(Xijing Hospital), Xiao Liu(Xijing Hospital), Yalong He(Air Force Medical University), Haozhe Qin(Central South University)
Cited by 0
Related Papers
Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma
|ACS Nano|2023|181
Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
|ACS Nano|2023|116
NaSICON-type materials for lithium-ion battery applications: Progress and challenges
|Nano Energy|2024|55
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
|Journal of Nanobiotechnology|2023|38
Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma
|Journal of Experimental & Clinical Cancer Research|2022|28